Lowering Drug Prices by Putting America First

What it means

Orders Medicare to implement a "most-favored-nation" pricing model for prescription drugs, ensuring Americans pay no more than the lowest price offered to other developed nations. This aims to address high drug costs that force Americans to subsidize lower prices in other countries.

Expected impact

• Potential reduction in prescription drug prices for Medicare beneficiaries through implementation of international reference pricing
• Decreased financial burden on American seniors who rely on Medicare Part B and Part D prescription drugs
• Possible resistance from pharmaceutical companies concerned about revenue impacts
• Improved medication adherence as more affordable prices may prevent patients from skipping doses or abandoning treatments
• Challenge to the current model where Americans effectively subsidize lower drug prices in other countries